It is essential that new anti-human cytomegalovirus drugs rapidly progress through pre-clinical development. In partnership with Merck, Sharpe & Dohme, our laboratory will investigate replication of HCMV viral genomes produced from Letermovir treated cells with a view to understanding how HCMV can be detected in patients during Letermovir treatment. It is our aim to not only advance our understanding of viral DNA metabolism, but also create new paradigms in viral diagnostics.

The successful candidate will have a PhD in virology or molecular biology; previous experience with virus infection and quantitative PCR is essential. They will be hardworking with a proven scientific track record, preferably at least one first author paper, and a particular interest in addressing fundamental questions that involve the mechanisms of viral replication.

For an informal discussion to find out more about the role please contact bstrang@sgul.ac.uk

For further information about this position and to apply, visit http://jobs.sgul.ac.uk.

Flexible working, including part-time or reduced hours of work, opportunities to work from home for many posts, compressed hours and local flexibility in agreeing start and finish times of work are among the extra benefits offered by St George’s, University of London.

Please quote reference: 176-20

Closing date:   14th September 2020

Interview date: Week commencing 5th October 2020